ZTS

#421
Zoetis Inc. Class A Common Stock
78.0 7 USD
-0.26%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
77.58
78.88
Range Annuel
0.78
147.90
Changement quotidien
-0.26%
Changement Mensuel
-31.67%
Evolution sur 6 mois
-39.15%
Changement Annuel
-46.64%
Clôture Précédente
78.2 7
Open
78.8 8
Low
77.5 8
High
78.8 8
Volume
914
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 32.73 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
20.9
ratio cours/chiffre d'affaires
5.9
Dividende par action
2.03
Rendement du dividende (%)
1.61

Zoetis Inc. Class A Common Stock

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Nouvelles